Mengliang Wu
Overview
Explore the profile of Mengliang Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu Y, Wu M, Li D, Habgood M, Chinnery H, Schneider-Futschik E
J Cyst Fibros
. 2024 Dec;
24(1):21-25.
PMID: 39643543
Background And Objective: Elexacaftor-tezacaftor-ivacaftor (ETI) is a drug treatment for cystic fibrosis that is debatable for use in pregnant women. Fetal ocular changes following prenatal exposure and while breastfeeding to...
2.
Bedggood P, Wu M, Zhang X, Rajan R, Wu C, Karunaratne S, et al.
Biomed Opt Express
. 2024 Nov;
15(11):6277-6298.
PMID: 39553868
confocal microscopy (IVCM) is a widely used technique for imaging the cornea of the eye with a confocal scanning light ophthalmoscope. Cellular resolution and high contrast are achieved without invasive...
3.
Wu M, Fletcher E, Chinnery H, Downie L, Mueller S
Nat Rev Immunol
. 2024 Aug;
24(12):896-911.
PMID: 39215057
Balanced immune responses in the eyes are crucial to preserve vision. The ocular immune system has long been considered distinct, owing to the so-called 'immune privilege' of its component tissues....
4.
Britten-Jones A, Wu M, Roberts L, MacIsaac R, Jiao H, Craig J, et al.
Ocul Surf
. 2024 Aug;
34:309-316.
PMID: 39153598
Aims: To investigate tear neuropeptide Y (NPY) and substance P concentrations in individuals with type 1 diabetes, comparing those with and without both diabetic retinopathy (DR) and peripheral neuropathy. Methods:...
5.
Wu M, Zhang X, Karunaratne S, Lee J, Lampugnani E, Selva K, et al.
Ophthalmology
. 2024 May;
131(10):1185-1195.
PMID: 38703795
Purpose: Defining how the in vivo immune status of peripheral tissues is shaped by the external environment has remained a technical challenge. We recently developed Functional in vivo confocal microscopy...
6.
Downie L, Zhang X, Wu M, Karunaratne S, Loi J, Senthil K, et al.
Proc Natl Acad Sci U S A
. 2023 Jul;
120(31):e2217795120.
PMID: 37487076
The healthy human cornea is a uniquely transparent sensory tissue where immune responses are tightly controlled to preserve vision. The cornea contains immune cells that are widely presumed to be...
7.
Wu M, Chinnery H, De Silva M, Downie L
Clin Exp Ophthalmol
. 2023 Jul;
51(7):746-749.
PMID: 37463834
No abstract available.
8.
Lv J, Wu M, Pang C, Duan R, Zhang H, Tian S, et al.
Biomed Pharmacother
. 2023 May;
163:114858.
PMID: 37172335
Torsemide is commonly used to relieve edema during the treatment of acute promyelocytic leukemia (APL) with arsenic trioxide (ATO). We explored the effect of torsemide on the plasma concentrations of...
9.
Wu M, Pang C, Lu S, Hostetter T, Hai X
Environ Toxicol Pharmacol
. 2023 May;
100:104142.
PMID: 37146668
Our study aimed to explore whether type 2 diabetes (T2DM) can affect arsenic metabolism in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide. We found that compared with non-diabetic...
10.
Gao C, Lin L, Li J, Wu M, Lv J, Tian S, et al.
Toxicol Lett
. 2023 Apr;
380:31-39.
PMID: 37024065
Arsenic trioxide (AsO) has prominent effect in treating acute promyelocytic leukemia (APL). Identification of arsenic-binding proteins has gained attention for their important biological functions. However, none has been published concerning...